Clinical Trial Update: Safety and Efficacy Study of S-309309 in Obese Adults [Phase 2]

View source ↗

Summary

This clinical trial update covers the completed Phase 2 safety and efficacy study of S-309309 in obese adults. The sponsor is Shionogi.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• S-309309

Snippet

Sponsor: Shionogi | Conditions: Obesity | Phase 2 | Status: COMPLETED